Related references
Note: Only part of the references are listed.Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Carolin Heller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Shorena Janelidze et al.
NATURE MEDICINE (2020)
Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project
Inge M. W. Verberk et al.
NEUROBIOLOGY OF AGING (2020)
Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study
Frank de Wolfa et al.
BRAIN (2020)
Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia
Yan Sun et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study
Kumar B. Rajan et al.
ANNALS OF NEUROLOGY (2020)
Combination of plasma amyloid beta(1-42/1-40)and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Inge M. W. Verberk et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study (vol 18, pg 1103, 2019)
E. L. van der Ende et al.
LANCET NEUROLOGY (2020)
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project
Tessa Timmers et al.
NEUROBIOLOGY OF AGING (2019)
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease
Philip S. J. Weston et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
Plasma and CSF neurofilament light Relation to longitudinal neuroimaging and cognitive measures
Michelle M. Mielke et al.
NEUROLOGY (2019)
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia
Rosalinde E. R. Slot et al.
ALZHEIMERS & DEMENTIA (2019)
Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment
Patrick Oeckl et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
Emma L. van der Ende et al.
LANCET NEUROLOGY (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M. W. Verberk et al.
ANNALS OF NEUROLOGY (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results
Rosalinde E. R. Slot et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results
Betty M. Tijms et al.
CLINICAL CHEMISTRY (2018)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role
C. J. Garwood et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)
A practical guide to immunoassay method validation
Ulf Andreasson et al.
FRONTIERS IN NEUROLOGY (2015)
Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
Wiesje M. van der Flier et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Preclinical AD predicts decline in memory and executive functions in subjective complaints
Argonde C. van Harten et al.
NEUROLOGY (2013)
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment
Lukas Scheef et al.
NEUROLOGY (2012)
Share Paper
